Clinical Trials Directory

Trials / Completed

CompletedNCT05909228

Bone Markers in Pediatric IF

Bone Turnover Markers in Children With Intestinal Failure After Optimization of Parenteral Nutrition

Status
Completed
Phase
Study type
Observational
Enrollment
35 (actual)
Sponsor
The Hospital for Sick Children · Academic / Other
Sex
All
Age
6 Weeks – 18 Years
Healthy volunteers

Summary

Poor bone health is a well-recognized but poorly understood complication in children with intestinal failure (IF) who are dependent on parenteral nutrition (PN). Previously, we showed that children with IF have decreased bone turnover markers. It is currently unknown if optimization of parenteral nutrition is related to improved bone turnover markers. Serum concentrations of bone markers (osteocalcin, bone-specific alkaline phosphatase and c-telopeptide) will be measured in 30 IF patients treated at a multidisciplinary intestinal rehabilitation and home PN program at the Hospital for Sick Children and compared to bone markers in 30 age- and sex-matched healthy controls.

Detailed description

It is currently unknown if optimization of PN mixtures leads to a measurable change in bone turnover markers. Our hypothesis is that bone turnover markers of children with IF whose PN has been optimized will not differ from those of healthy control subjects, with a positive effect on bone mineral density. Our aims are: * To measure bone turnover markers in children with IF on long-term PN and compare them with age- and sex-matched healthy children who never received PN * To evaluate if changes in bone turnover markers are related to changes in bone mineral density measured by Dual energy X-ray absorptiometry (DXA) * To identify IF- and PN-related factors associated with bone health To be able to answer these aims, bone markers in children with IF will be compared to bone markers in healthy controls, age- and sex-matched.

Conditions

Timeline

Start date
2023-03-31
Primary completion
2023-09-30
Completion
2023-09-30
First posted
2023-06-18
Last updated
2024-01-16

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05909228. Inclusion in this directory is not an endorsement.

Bone Markers in Pediatric IF (NCT05909228) · Clinical Trials Directory